Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025
Castle Biosciences (CSTL) has announced it will release its fourth quarter and full-year 2024 financial results after market close on Thursday, February 27, 2025. The company will host a conference call and webcast at 4:30 p.m. Eastern time to discuss the results.
Investors can access the live webcast through the company's Investor Relations page or directly via the provided link. For those joining by phone, the U.S. dial-in number is 1-833-470-1428 with access code 944585. International dial-in numbers are available through a separate link. A Q&A session will follow management's presentation, and a webcast replay will be available after the call.
Castle Biosciences (CSTL) ha annunciato che rilascerà i propri risultati finanziari del quarto trimestre e dell'intero anno 2024 dopo la chiusura del mercato giovedì 27 febbraio 2025. L'azienda ospiterà una conferenza telefonica e una trasmissione in diretta alle 16:30 ora orientale per discutere i risultati.
Gli investitori possono accedere alla trasmissione in diretta tramite la pagina delle Relazioni con gli investitori dell'azienda o direttamente tramite il link fornito. Per coloro che partecipano telefonicamente, il numero di accesso negli Stati Uniti è 1-833-470-1428 con codice di accesso 944585. I numeri di accesso internazionali sono disponibili tramite un link separato. Seguirà una sessione di domande e risposte dopo la presentazione della direzione, e una registrazione della trasmissione sarà disponibile dopo la chiamata.
Castle Biosciences (CSTL) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre del mercado el jueves 27 de febrero de 2025. La compañía llevará a cabo una llamada de conferencia y una transmisión web a las 4:30 p.m. hora del Este para discutir los resultados.
Los inversores pueden acceder a la transmisión en vivo a través de la página de Relaciones con Inversores de la compañía o directamente a través del enlace proporcionado. Para aquellos que se unan por teléfono, el número de acceso en EE. UU. es 1-833-470-1428 con el código de acceso 944585. Los números de acceso internacionales están disponibles a través de un enlace separado. Después de la presentación de la dirección, habrá una sesión de preguntas y respuestas, y se podrá acceder a una repetición de la transmisión después de la llamada.
캐슬 바이오사이언스(CSTL)가 2024년 4분기 및 연간 재무 결과를 2025년 2월 27일 목요일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 결과에 대해 논의하기 위해 동부 표준시 기준 오후 4시 30분에 전화 회의 및 웹캐스트를 개최합니다.
투자자는 회사의 투자자 관계 페이지를 통해 또는 제공된 링크를 통해 라이브 웹캐스트에 접근할 수 있습니다. 전화로 참여하는 분들을 위해 미국 통화번호는 1-833-470-1428이며, 액세스 코드는 944585입니다. 국제 통화번호는 별도의 링크를 통해 제공됩니다. 경영진의 발표 후 질의응답 세션이 진행되며, 통화 후 웹캐스트 재생도 가능합니다.
Castle Biosciences (CSTL) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année 2024 après la clôture du marché le jeudi 27 février 2025. L'entreprise organisera une conférence téléphonique et un webinaire à 16h30, heure de l'Est, pour discuter des résultats.
Les investisseurs peuvent accéder au webinaire en direct via la page des Relations Investisseurs de l'entreprise ou directement via le lien fourni. Pour ceux qui participent par téléphone, le numéro d'appel des États-Unis est le 1-833-470-1428 avec le code d'accès 944585. Des numéros d'appel internationaux sont disponibles via un lien séparé. Une session de questions-réponses suivra la présentation de la direction, et une rediffusion du webinaire sera disponible après l'appel.
Castle Biosciences (CSTL) hat angekündigt, dass die Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 nach Börsenschluss am Donnerstag, den 27. Februar 2025 veröffentlicht werden. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen.
Investoren können über die Investor-Relations-Seite des Unternehmens oder direkt über den bereitgestellten Link auf den Live-Webcast zugreifen. Für diejenigen, die telefonisch teilnehmen, ist die US-Dial-In-Nummer 1-833-470-1428 mit dem Zugangscode 944585. Internationale Dial-In-Nummern sind über einen separaten Link verfügbar. Nach der Präsentation des Managements wird eine Frage- und Antwortsitzung stattfinden, und eine Wiederholung des Webcasts wird nach dem Anruf verfügbar sein.
- None.
- None.
Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day.
Conference Call and Webcast Details
A live webcast of the conference call can be accessed here: https://events.q4inc.com/attendee/686536610, or via the webcast link on the Investor Relations page of the Company’s website: https://ir.castlebiosciences.com/overview/default.aspx. Please access the webcast at least 10 minutes before the conference call start time. A replay of the webcast will be available following the conclusion of the conference call.
To access the live conference call via phone, please dial 1 833 470 1428 from
There will be a brief Question and Answer session following management commentary.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250206051505/en/
Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact:
amarshall@castlebiosciences.com
Source: Castle Biosciences Inc.
FAQ
When will Castle Biosciences (CSTL) release Q4 and full-year 2024 earnings?
What time is Castle Biosciences (CSTL) Q4 2024 earnings call?
How can I access Castle Biosciences (CSTL) Q4 2024 earnings call?
Will there be a Q&A session during CSTL's Q4 2024 earnings call?
